AKBA Stock-Based Compensation
Akebia Therapeutics Inc · Stock-Based Compensation
AKBA Stock-Based Compensation
Latest reported$13.31Mperiod ending
AKBA TTM Stock-Based Comp ($1.56M → $13.31M)
TTM stock-based compensation
High-resolution chart · PNG
AKBA stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 13,314,000 | |
| 12,764,000 | |
| 11,283,000 | |
| 9,781,000 | |
| 8,206,000 | |
| 7,602,000 | |
| 7,775,000 | |
| 7,592,000 | |
| 7,770,000 | |
| 9,188,000 | |
| 9,317,000 | |
| 10,844,000 | |
| 12,375,000 | |
| 15,802,000 | |
| 17,849,000 | |
| 19,444,000 | |
| 21,682,000 | |
| 21,279,000 | |
| 22,735,000 | |
| 24,187,000 | |
| 25,186,000 | |
| 25,536,000 | |
| 24,460,000 | |
| 23,306,000 | |
| 19,327,000 | |
| 14,747,000 | |
| 11,925,000 | |
| 19,053,000 | |
| 18,693,000 | |
| 18,902,000 | |
| 19,040,000 | |
| 9,171,000 | |
| 9,070,000 | |
| 5,670,000 | |
| 8,867,000 | |
| 8,398,000 | |
| 7,874,000 | |
| 10,003,000 | |
| 5,825,000 | |
| 5,429,000 | |
| 4,964,000 | |
| 4,837,000 | |
| 4,714,000 | |
| 4,271,000 | |
| 4,344,192 | |
| 4,693,136 | |
| 6,010,000 | |
| 6,250,759 | |
| 5,344,774 | |
| 3,952,231 | |
| 1,563,759 | |
| 429,458 |